MAPT and Alzheimer disease: In addition, (1) reduced NAA levels have been associated with an increased risk of conversion from MCI to AD dementia,65, 68 and (2) lower NAA/tCr early in the AD continuum were associated with amyloid beta and tau—two hallmark AD pathologies.69